Conversely, CD52 and KRT19 were identified as predictive biomarkers linked to the tumour microenvironment (TME) of BC,39, 42, 43 whereas genetic variations in IL7R dramatically raised the susceptibility to BC in Chinese Han women.38 The gene discussed is CD52; the disease is breast cancer.